Former Chief Financial Officer · Praxis Precision Medicines, Inc. (PRAX)

Stuart Chaffee

A named executive officer of Praxis Precision Medicines in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,647,683

Salary $341,114Stock awards $0

FY2019: $391,775

4th of 5 named executive officers at Praxis Precision Medicines by FY2020 total.

5 named officers on file for Praxis Precision Medicines, FY2020

Stuart Chaffee’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • PRAX’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Praxis Precision Medicines’s whole pay program stands against its peers

  • Praxis Precision Medicines’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PRAX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A).

Free

Get Stuart Chaffee’s full pay file as a PDF — free

More than this page: up to 10 years of Stuart’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Stuart Chaffee compensation by year

Praxis Precision Medicines Summary Compensation Table · all 2 fiscal years held
In US dollars, as Praxis Precision Medicines reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$308,250$341,114
Bonus$0$0
Stock awards$0$0
Option awards$0$852,959
Non-equity incentive$83,228$0
Pension and deferred compensation$0$0
All other$297$453,610
Total$391,775$1,647,683

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Praxis Precision Medicines, Inc. DEF 14A filed April 29, 2021, accession 0001689548-21-000028, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Praxis Precision Medicines, Inc. filed document, accession 0001689548-21-000028. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

$392K
$1.6M
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option65,892—$5.59
Option40,002—$2.27
Option93,457—$8.91

Per the Outstanding Equity Awards at Fiscal Year-End table in Praxis Precision Medicines, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Praxis Precision Medicines’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Marcio SouzaPresident and Chief Executive Officer$11,741,959
Bernard RavinaChief Medical Officer$1,711,010
Nicole SweenyChief Commercial Officer$1,654,052
Stuart Chaffee · this pageFormer Chief Financial Officer$1,647,683
Kiran ReddyFormer President and Chief Executive Officer$149,242

The full Praxis Precision Medicines compensation record

free company brief

This page is one person within Praxis Precision Medicines's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Praxis Precision Medicines proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Praxis Precision Medicines's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stuart Chaffee's compensation dossier · One-time report. No refunds.